Research and development consultancy services

Tender description

The UK Government has recently announced the development of the Fleming Fund that will support low and middle income countries in tackling anti-microbial resistance (AMR). Drug-resistant infections could kill an extra 10 million people across the world every year by 2050 if they are not tackled. By this date they could also cost the world around $100 trillion in lost output: more than the size of the current world economy (Review on Antimicrobial Resistance, 2014). Both the Prime Minister and Chief Medical Officer have announced that tackling AMR at home and abroad is a key priority and that the UK will help to lead a global response in this field. To facilitate this, the Department of Health is working closely with the Department for International Development (DFID) to establish programmes aimed at supporting low and middle income countries, where there remains very little data on the extent of the problem or what priority actions should be taken. The Department of Health (DH) plans to release a tender for a management agent to deliver the main disbursement of funds through country and regional projects. It is anticipated that the management agent will have a good level of experience in high value grant management in low and middle income countries. The agent will be an organisation or consortia and will manage the programme itself with its country and regional projects. The management agent will need to: — draw on relevant technical expertise in AMR; — manage and monitor multiple country and regional projects around the world; — undertake due diligence on An initial pre-procurement engagement event was held on the 3/12/15 followed by one to one sessions in January 2016. The event tested some of the key questions on scope, challenges, opportunities and potential costs of the fund; as well as discussing in more detail the role and remit of the management agent. This will be part of a number of engagement opportunities.